World's best Tablets for osteoporosis in men and women | HANLIM

HANLIM PHARM. CO., LTD. is one of leading Korean pharmaceutical manufacturers. Since its establishment in 1974, Hanlim have constantly put the entire effort to develop and provide a wide range of quality products under the company ideology, “To save noble life of a human from various diseases”. Hanlim is continuing long-term investment as technology accumulation and secure advanced research personnel for developing new medicine by establishing a central research lab, and developing advanced medicine will be the core of Hanlim’s vision which will become the foothold for Hanlim to become a global firm. Hanlim not only provides the product information that should be delivered to you but also tries the best to provide more various information and data.

 

Especially, since medical supply is directly related to life, the final consumer is a patient, not a doctor who selects the medical supply, and provision of unreasonable prizes through by tempting supply purchase means from the cost using public resources can cause more critical damage than other industries. In order to constantly manage society’s faith and credit of total medical supplies, it is necessary to maintain and stimulate impartial, clear, and free competition other than unreasonable sales promotion action in medical supply. In such a view, Hanlim should settle compliance program to prevent action violating fair trade rules as well as thorough compliance to promote realization of clear and fair trade.

 

Hanlim's RISENEX PLUS Tablets for osteoporosis in men:

The Hanlim's RISENEX PLUS tablets is a solution for the treatment and prevention of postmenopausal syndrome. RISENEX PLUS tablets are used to treat osteoporosis in men with the composition of sodium risedronate 35mg and cholecalciferol conc. 56mg (5,600 I.U.). The packing of Hanlim's RISENEX PLUS is 4 tablets/PTP with a shelf life of 3 years.

 

Hanlim's RISENEX M Tablets for osteoporosis in women:

The Hanlim's RISENEX M tablets are a solution for the treatment and prevention of postmenopausal syndrome. RISENEX PLUS tablets are used to treat osteoporosis in women with the composition of sodium risedronate 150mg and cholecalciferol conc. 0.75mg (30,000 I.U.). The packing of Hanlim's RISENEX M is 1 tablet/PTP with a shelf life of 3 years.

 

Click here to contact us.

View more: Tablets for osteoporosis in men and women